Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults.

about

Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults.

Item

http://www.wikidata.org/entity/Q49184899

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Efficacy and safety of dupilum ...... e atopic dermatitis in adults.

@en

Efficacy and safety of dupilum ...... e atopic dermatitis in adults.

@nl

type

Item

label

Efficacy and safety of dupilum ...... e atopic dermatitis in adults.

@en

Efficacy and safety of dupilum ...... e atopic dermatitis in adults.

@nl

prefLabel

Efficacy and safety of dupilum ...... e atopic dermatitis in adults.

@en

Efficacy and safety of dupilum ...... e atopic dermatitis in adults.

@nl

P1476

Efficacy and safety of dupilum ...... e atopic dermatitis in adults.

@en

P2093

Chengxin Li

http://www.w3.org/2001/XMLSchema#string

Xin Zhang

http://www.w3.org/2001/XMLSchema#string

Xinghua Xu

http://www.w3.org/2001/XMLSchema#string

Yanling He

http://www.w3.org/2001/XMLSchema#string

Yi Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study.

Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.

Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.

Mental health comorbidity in patients with atopic dermatitis.

Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods.

Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.

Targeting key proximal drivers of type 2 inflammation in disease.

Drug evaluation review: dupilumab in atopic dermatitis.

P304

108480-108491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22499

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29312544

http://www.w3.org/2001/XMLSchema#string

P932

5752457

http://www.w3.org/2001/XMLSchema#string